It’s crazy to think we have a share price less then what we had prior to MS results, makes you think is it that good. You guys should start hacking away at 0.20 otherwise you are at risk of me hanging around because not much to buy above 0.18. Look I would love NSB to rocket back to 0.30 on the final report and quarterly but I focus on similar results and it’s effectiveness with the so, Glaucoma did nothing, can anyone tell me why they think the final report for MS will do anything different?
Ann: EmtinB Positive Results in MS, page-100
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
